课题基金 / 基金详情

RETINOID MEDIATED ANTICANCER ACTIVITIES

RETINOID MEDIATED ANTICANCER ACTIVITIES
视黄醇介导的抗癌活性
批准号:
2894913
负责人:
MAGNUS Pfahl PFAHL
金额:
$28.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-01 至 2001-04-30

项目摘要

项目成果

MAGNUS Pfahl PFAHL的其他基金

相似基金

相关文献

中文摘要
翻译
近年来的进步大大改善了
英文摘要
DESCRIPTION: Progress made in recent years has greatly improved the understanding of the molecular mechanisms of retinoid action and now allows the design of retinoids which are highly selective, more potent than natural compounds, and also promise to have fewer side effects. In this proposal, lung cancer cells will be studied as a model system with a series of novel retinoids that have shown promising anti-cancer activities. The applicant will compare the activity of his novel retinoids to retinoic acid in a series of different lung cancer cell lines, including non-small cell and small cell lung cancer cells, and will analyze the molecular mechanisms underlying the enhanced anti-cancer activities of the retinoids. As it is unlikely that a single agent can be identified that specifically cures lung cancer, the applicant will also examine cooperativity between his highly active retinoids and other agents including vitamin D3 (VD) and interferons (IFNs). These investigations are designed to provide fundamental data on the molecular mechanisms of action related to inhibition of lung cancer cell growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New ultra-selective kinase inhibitors for the treatment of AML
  • 批准号:
    8313208
  • 项目类别:
  • 资助金额:
    $24.85万
  • 财政年份:
    2012
  • 负责人:
    MAGNUS Pfahl PFAHL
  • 依托单位:
RETINOID MEDIATED ANTICANCER ACTIVITIES
  • 批准号:
    2096800
  • 项目类别:
  • 资助金额:
    $26.55万
  • 财政年份:
    1992
  • 负责人:
    MAGNUS Pfahl PFAHL
  • 依托单位:
ANALYSIS OF RETINOID MEDIATED ANTI-CANCER ACTIVITIES
RETINOID MEDIATED ANTICANCER ACTIVITIES
  • 批准号:
    2700471
  • 项目类别:
  • 资助金额:
    $28.13万
  • 财政年份:
    1992
  • 负责人:
    MAGNUS Pfahl PFAHL
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: